what are glp-1 medications used for Agonists - is it? Long-term Success of GLP-1s Hinges

There are also many other factors influencing the risk of developing obesity, including genetics, cultural factors, the characteristics of social and physical environments one lives in, and many others (e.g., Angl et al., 2009

Rodrguez Toboso, G

We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them, said Ed Cinca, the senior vice-president of marketing and patient solutions at Novo Nordisk

It helps with weight loss and supports metabolic health, making it ideal for those with a BMI of 30 or higher, or a BMI of 27 with obesity-related conditions like high blood pressure, high cholesterol, prediabetes, or type 2 diabetes

CVD prevention

To receive a prescription of either medication through the NHS you must: have a BMI of 40 or more (or 37.5 and above for certain ethnic groups) have at least at least four weight-related health conditions, such as type 2 diabetes, high blood pressure, heart disease, or sleep apnoea have the medication prescribed through a specialist weight management service Differences Licencing Mounjaro is licenced and approved in the UK for loss treatment